Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089109 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,780
Total Value
$40,671.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | Common Stock | โ | Mar 2, 2026 | Tax Withholding | 148 | $23.39 | $3,461.72 | 50,302 | Direct | โ | View Details | |
SVP, Chief Accounting Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,632 | $22.80 | $37,209.60 | 48,670 | Direct | โ | View Details |